J. Barker

Cell trafficking and role of adhesion molecules in psoriasis.

J. Barker, C. Smith, Catherine Smith, 1995, Clinics in dermatology.

Polymorphisms in the PTPN22 region are associated with psoriasis of early onset

Aldo von Wangenheim, Christiane Gresse von Wangenheim, Andre Bortolon, 2008, The British journal of dermatology.

Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register

A. Burden, N. Reynolds, I. Iskandar, 2015, The British journal of dermatology.

Secukinumab for patients failing previous tumour necrosis factor‐α inhibitor therapy: results of a randomized open‐label study (SIGNATURE)

A. Finlay, A. Burden, C. Griffiths, 2020, The British journal of dermatology.

Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study

J. Barker, E. Wain, C. Smith, 2010, The British journal of dermatology.

Methotrexate polyglutamates as a marker of patient compliance and clinical response in psoriasis: a single‐centre prospective study

C. Lewis, S. West, J. Barker, 2012, The British journal of dermatology.

Global reporting of cases of COVID‐19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic

N. Dand, F. Capon, S. Mahil, 2020, The British journal of dermatology.

Psoriasis and its management

J. Barker, Catherine H. Smith, J. Barker, 2006, BMJ : British Medical Journal.

Screening for anxiety and depression in people with psoriasis: a cross‐sectional study in a tertiary referral setting

Charles H. Smith, M. Hotopf, F. Matcham, 2017, The British journal of dermatology.

Infliximab for the treatment of psoriasis in the U.K.: 9 years’ experience of infusion reactions at a single centre

G. Petrof, J. Barker, C. Smith, 2012, The British journal of dermatology.